Researchers discover two treatments that induce peanut allergy remission in children

The research, led by the Murdoch Children’s Research Institute (MCRI), found the treatments – a combination of a probiotic together with oral immunotherapy (the gradual introduction of the allergenic food) and oral
immunotherapy alone – significantly induced remission and desensitisation.

Media release (prota) Achieves Peanut Allergy Treatment Milestone

Groundbreaking Clinical Trial Data Demonstrates Clinical Remission of Peanut Allergy in Paediatric Patients

Media Release (Prota) PPOIT-003 fully enrolled

Prota/MCRI completes enrolment of Phase 2b multicentre clinical trial of probiotic oral immunotherapy for the treatment of peanut allergy (PPOIT-003)

Business Wire, Prota Four year data announcement Aug 2017

New Data Shows Previously Allergic Children Still Able to Tolerate Peanut Four Years after Treatment with a Novel Immunotherapy Licensed by Prota Therapeutics